BioNTech Founders Exit to Launch New mRNA Venture Amid FDA Investigation
BioNTech's founders are departing to start a new mRNA company amidst ongoing FDA treatment denial investigations. This strategic move could impact the biotech industry and vaccine development.
· 87d ago
